1. The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.
- Author
-
Midura-Nowaczek K, Kaczyńska J, Bruzgo I, Markowska A, and Drozdowska D
- Subjects
- Aminocaproic Acid pharmacology, Animals, Antifibrinolytic Agents pharmacology, Blood Coagulation, Cattle, Cysteine pharmacology, Fibrinogen metabolism, Fibrinolysis, Hemorrhage, Humans, Models, Biological, Peptides chemistry, Saliva metabolism, Time Factors, Tissue Plasminogen Activator antagonists & inhibitors, Tranexamic Acid pharmacology, Aminocaproates, Cysteine analogs & derivatives, Saliva drug effects, Tissue Plasminogen Activator metabolism
- Abstract
Purpose: The aim of this work was to study the effect of the synthetic antifibrinolytics: ε-aminocaproic acid (EACA), tranexamic acid (AMCHA) and ε-aminocaproyl-S-benzyl-L-cysteine (H-EACA-S-Bzl-L-Cys-OH) on the fibrinolytic activity of saliva in order to obtain new data on the activity of saliva tissue plasminogen activator (t-PA)., Material and Methods: Saliva samples were obtained from healthy volunteers. Saliva, precipitate and supernatant were tested 1hr, 4 hrs and 6hrs after collection. The effect of the synthetic antifibrinolytics was examined with the use of the clot lysis time determination., Results: All examined compounds inhibited the fibrinolytic activity of saliva 1hr after collection. H-EACA-S-Bzl-L-Cys-OH was the most active inhibitor. After 6 hours in room temperature only this compound showed a certain possibility to prolong the clot lysis time., Conclusions: The obtained results may indicate the possibility of the difference in specificity between the activities of t-PA of saliva and recombinant tissue plasminogen activator activities. It may explain the unexpected high inhibitory activity of H-EACA-S-Bzl-L-Cys-OH in our study.
- Published
- 2011
- Full Text
- View/download PDF